The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.
Some new organozirconium(IV) compounds with N-(aryl)-2-mercaptoacetamides
作者:Satish C. Dixit、Ram Sharan、Ramesh N. Kapoor
DOI:10.1016/0022-328x(87)85132-x
日期:1987.9
Reactions of dichlorodicyclopentadienylzirconium(IV) with various stoichiometric proportions of mercaptoacetamides have been examined. Complexes of the type Cp2Zr(MA)Cl and Cp2Zr(MA)2 (Cp Cyclopentadienyl and MAH N-(aryl)-2-mercaptoacetamide; aryl phenyl, o-tolyl, m-tolyl, p-tolyl, α-naphthyl or 3,5-dimethylphenyl) were obtained, and were characterized by elemental analysis and by 1H NMR, variable
已经研究了二氯二环戊二烯基锆(IV)与各种化学计量比例的巯基乙酰胺的反应。该类型的复合物的CP 2 Zr的(MA)Cl和的CP 2 Zr的(MA)2(CP环戊二烯基和MAH ñ - (芳基)-2-巯基乙酰胺;芳基苯基,ö甲苯基,米间-甲苯基,p -得到甲苯基,α-萘基或3,5-二甲基苯基),并通过元素分析和1 H NMR,可变温度1 H NMR,IR和电子光谱数据进行表征。
ION CHANNEL MODULATORS
申请人:Zelle Robert
公开号:US20080090891A1
公开(公告)日:2008-04-17
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.